Get a Sample
Schedule a Meeting
Get a Sample
Table Of Content
May 2025
The global insulin pump market size was accounted for USD 6.58 billion in 2024, grew to USD 7.12 billion in 2025 and is predicted to surpass around USD 14.54 billion by 2034, representing a healthy CAGR of 8.25% between 2025 and 2034. The rising prevalence of diabetes, increasing adoption of advanced insulin delivery technologies, and growing awareness of diabetes management.
The global insulin pump market size was estimated at USD 6.58 billion in 2024 and is anticipated to reach around USD 14.54 billion by 2034, expanding at a CAGR of 8.25% from 2025 to 2034.
The U.S. insulin pump market size was evaluated at USD 2.12 billion in 2024 and is predicted to be worth around USD 4.77 billion by 2034, rising at a CAGR of 8.45% from 2025 to 2034.
North America accounted revenue share of over 47% in 2024. The presence of numerous top market players in the region coupled with the increased prevalence of diabetes and increased demand for the innovative drug delivery devices among the population has fostered the growth of the insulin pump market in North America. The increased disposable income and increased health consciousness has triggered the adoption of the insulin pumps among the population and the region is projected to retain its dominant position throughout the forecast period.
On the other hand, Asia Pacific is estimated to be the most opportunistic segment during the forecast period. Asia Pacific is home to around 4.4 billion people and the changing consumption pattern and unhealthy food habits of the consumers is resulting in a surge in the diabetic population. Moreover, growing health awareness, rising penetration of the retail pharmacies, and rising consumer expenditure on the healthcare in the region is expected to drive the growth of the insulin pump market in Asia Pacific in the foreseeable future.
Insulin pumps are compact computerized drug delivery devices that enables the delivery of the insulin doses in required amount into a diabetic patient. The increased efficiency of the insulin pumps in managing and controlling the diabetes regularly by providing consistent and timely delivery of the insulin doses to the patients has fostered the adoption of the insulin pumps across the globe.
The demand for the insulin pumps is primarily driven by the growing prevalence of diabetes among the population. As per the data revealed by the International Diabetes Federation, around 552 million people across the globe are estimated to have diabetes by the year 2030. According to the World Health Organization, diabetes is a major cause of blindness, stroke, and kidney failure. The changing lifestyle of the consumers, shifting consumption pattern, and unhealthy food habits of the people is surging the cases of diabetes among the global population.
The rising awareness regarding the availability of the advanced innovative pumps and its easy availability are the major factors that drives the growth of the global insulin pump market. The rising investments by the market players in the research and innovation of the drug delivery devices has encouraged the development of the insulin pumps that primarily focuses on the convenience of the patients is fueling the market growth.
Furthermore, the integration of smart technologies like artificial intelligence in the healthcare sector is propelling the adoption of the automated insulin pumps among the patients. Moreover, rising number of product approvals and various developmental strategies such as partnerships, distribution agreements, and collaborations adopted by the market players is positively influencing the growth of the global insulin pump market.
| Report Coverage | Details |
| Market Size by 2024 | USD 6.58 Billion |
| Market Size in 2025 | USD 7.12 Billion |
| Market Size in 2034 | USD 14.54 Billion |
| Market Growth Rate from 2025 to 2034 | CAGR of 8.25% |
| Leading Region | North America |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Pump Type, Accessories, End User |
Rising Prevalence of Diabetes
One of the major factors that has stimulated the insulin pump market is the increasing diabetes across the entire world. Both Type 1 and Type 2 diabetes are on the rise owing to various factors, which include the aging of populations, poor dietary patterns, obesity, and highly sedentary lifestyles. Since diabetes is becoming ranked by a lot of persons, the need to have efficient and effective delivery of insulin becomes higher. These devices are especially beneficial to Type 1 diabetics and to insulin-dependent Type 2 patients. Moreover, the insulin pump is becoming more appealing and accessible due to technological changes, such as its integration with continuous glucose monitors (CGMs) and the emergence of closed-loop systems.
Source: www.ncbi.nlm.nih.gov
High Cost of Insulin Pumps to Limit Their Adoption
One of the inhibitory factors of the widespread usage of insulin pumps is that their cost is high. Although these smart devices are transforming the way diabetes is managed in a way that provides much more control and flexibility, they remain unaffordable in many ways. The high cost of an insulin pump to purchase, with additional costs associated with regular consumable equipment such as infusion sets, reservoirs, and batteries. This hinders affordability by major proportions of the diabetes population, particularly in the developing world, where medical facilities and reimbursement strategies are not that fine-tuned.
Rise in Demand for User-Friendly Devices
Patients are demanding less invasive, simple-to-use, and convenient solutions that manage diabetes. Real-time data visualization, smartphone connection, and touchscreen interface embedded on insulin pumps raise convenience and connectivity for patients. Also, smaller and wearable solutions make patients more comfortable, and their limited size promotes long-term compliance. With increased consciousness concerning diabetes management and lifestyle demands, manufacturers stand a good chance of gaining a market share on individualized insulin pump solutions that are easy to use.
The MiniMed segment led the Insulin pump market and accounted for the largest revenue share in 2024. Mainly because of its wide usage and high technological functionalities. The manufacturer of MiniMed insulin pump, Medtronic, has gained a firm regional presence and brand loyalty, especially with the introduction of the MiniMed 670G system, which has received accreditation as the world very first hybrid closed-loop insulin delivery system. These pumps have built-in continuous glucose monitoring that allows the tracking of blood glucose levels in real time, and automatically adjust the amount of insulin. This automation is found to improve glycemic control as well as reduce the risk and manual interventions. The system can function 24/7, so in addition to patients having enhanced control over their condition, it also enables healthcare providers to base their clinical decisions on data.
Source: news.medtronic.com
The tandem segment is expected to grow at a significant CAGR over the forecast period. Associating itself with its user-friendliness assured, the big color touchscreen interface of the t: slim X2 is especially useful to patients with less dexterity and enhances the overall usability. This artificial intelligence-enabled closed-loop system automatically adjusts insulin delivery according to the insulin delivery. The personalized insulin management and smart connectivity of Tandem make it a competitive insulin pump. As the awareness and the patient preference to use more technologically advanced and easy-to-operate devices continue to rise, the Tandem segment will proliferate at a high rate.
Source : investor.tandemdiabetes.com
The tethered pump segment accounted market share of over 62% in 2024 with a CAGR of 9.4% over the forecast period. The increased adoption of the tethered insulin pumps owing to its portability and convenience that allows the patients to carry it in their pockets. Moreover, it can be connected with the handsets and allow easy control along with the monitoring of the blood glucose levels. Hence, these benefits have resulted in the increased demand for the tethered pumps.
On the other hand, the patch pump is estimated to grow at a CAGR of 10% during the forecast period. It is compact and allows remote control, which can also acts as a glues monitor. The patch pumps easy control of the doses and can be conveniently attached to the skin surface that offers convenience to the patients.
Type 1 diabetes segment dominated the market in 2024. Autoimmune type 1 diabetes is a response as the immune system of the body accidentally destroys and kills the insulin-producing beta cells in the pancreas. Due to the inability of the body to produce insulin, patients with this condition are treated with lifelong insulin therapy, which is generally given in various daily insulin injections or using insulin pumps. The advantage of insulin pumps is the level of accuracy in delivering and receiving insulin dosages when compared to the release of insulin in the body. The potential increase in the popularity of insulin pumps as a treatment for Type 1 diabetes is due to the rising consciousness of patients and health specialists, and insurance benefits in most developed areas.
The type 2 diabetes segment is expected to grow substantially in the Insulin pump market. The increased worldwide incidence of Type 2 diabetes (caused by ageing populations, inactive living, and poor diet) has led to increased interest in the more sophisticated diabetes associated instruments. The recent studies reveal that automated insulin delivery systems can improve glycemic control in Type 2 diabetes patients, bringing both the level of clinical outcomes improvement as well as the quality of life in general. Besides, the continuous R&D is reciprocating products in the form of various models of pumps that are targeted to suit the demands of diabetics with Type 2.
What Are the Key Trends Driving the Europe Insulin pump market?
The European insulin pump market is expected to account for a substantial market share in 2024. Enhanced through a cutting-edge healthcare facility, healthcare spending, and R&D investment. Countries like Germany, France, and the UK are in the lead in the region owing to the established health care systems and reimbursement policies. Diabetes is on the rise, particularly in the old-aged patients, which is increasing the market needs for technologically advanced insulin pumps. Efforts of governments dedicated to rapid market penetration are also centered on early diagnosis of diabetes, better access to care, and digital health tool support.
The insulin pump market in the U.K. is also growing at a rapid pace, and this is happening mainly because of the growing number of patients with type 1 diabetes, and the government is supporting diabetes care in this country. Under strict clinical criteria, insulin pumps are offered to eligible patients, especially children and adult patients requiring insulin pumps with poorly controlled type 1 diabetes, through the National Health Service (NHS).
The insulin set insertion devices segment accounted largest revenue share in 2024. This can be attributed to the extensive use of the insertion devices for conveniently attaching the insulin pumps to the skin surface. It provides accurate doses and helps to efficiently manage the blood glucose levels.
On the other hand, cartridges or the reservoir is estimated 9% CAGR during the forecast period. The increasing adoption of the tethered pumps among the patients is fostering the demand for the reservoirs. The reservoirs have a capacity to hold around 300 doses of insulin and it can last up to 3 days. Thus, the segment is expected to grow rapidly in the forthcoming years.
The hospitals segment dominated the market in 2024. This is simply attributed to the increased penetration of hospitals across the globe. The skilled healthcare professionals that can provide assistance to the diabetic patients in effectively curing diabetes has fueled the growth of the segment. The rising government and corporate investments in the advancements of the hospitals is expected to further fuel the growth of the hospitals segment in the near future.
On the other hand, the homecare is estimated to grow at a CAGR of 9.2% during the forecast period. The rising healthcare expenditure, increased awareness regarding the availability of the insulin pumps, and easy availability of the insulin pumps through the online and offline retail pharmacies is fostering the growth of the homecare segment significantly.
The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending on the development of improved products. Moreover, they are also focusing on maintaining competitive pricing.
The various developmental strategies like new product launches, acquisition, partnerships, and mergers fosters market growth and offers lucrative growth opportunities to the market players.
By Pump Type
By Product
By Application
By Disease Indication
By End User
By Geography
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
May 2025
August 2024
May 2025
August 2024